Moreover, to explore the possible regulation of AR and Nanog in ovarian cancer cells, the proliferation and migration abilities of single-clone Nanog GFP (+) cells with or without hormone treatments were examined (Figs. 5-6). This evidence concerns the gene NANOG and ovarian carcinoma.